Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hybrid brachytherapy with concurrent chemoradiation for locally advanced cervical cancer
jRCTs031180250Phase 2Completed
- Start
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of cisplatin in Cervical Cancer (CC). Primary endpoints: Phase I: rate of acute non-hematologic toxicity ≥ grade 3 attributed to hybrid brachytherapy and Phase II: 2-year pelvic relapse-free survival. Started Oct 2015; status: completed.
02
Drugs
cisplatin
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on jRCTs031180250.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031180250.